Search results
Big movers on D-Street: What should investors do with Raymond, RBL Bank and AstraZeneca India?
The Economic Times· 8 hours agoStocks that were in focus include names like Raymond, which rose 10%, RBL Bank, which fell 1.28%,...
AstraZeneca to invest Rs 250 crore for GCC expansion in Chennai
CNBC Awaaz· 4 days agoTN industries minister TRB Rajaa said rapid absorption of office spaces in Chennai underscores the...
AstraZeneca India to invest Rs 250 crore to expand its Global Innovation and Technology Centre - ET...
The Economic Times· 4 days agoChennai: AstraZeneca India Private Limited (AZIPL) announced an investment of Rs 250 crore ($30...
AstraZeneca to invest ₹250 crore to expand its global innovation and technology centre in Chennai
The Hindu· 4 days agoAstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of the company, has...
AstraZeneca invests $30M to expand global innovation centre in Chennai
YourStory· 4 days agoAstraZeneca India Private Limited on Thursday announced an investment of $30 million (Rs 250 crore)...
AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
Clinical Trials Arena· 3 days agoPharma giant AstraZeneca and UK biotech Aptamer Group are hoping to bolster the efficacy of small...
Volumes soar at Astrazeneca Pharma India Ltd counter
Business Standard India· 4 days agoAstrazeneca Pharma India Ltd clocked volume of 3.73 lakh shares by 14:14 IST on NSE, a 27.1 times surge over two-week average daily volume of 13755...
AstraZeneca’s Tagrisso plus chemotherapy wins EU approval for NSCLC
Pharmaceutical Technology· 3 days agoAstraZeneca has won approval from the European Commission for Tagrisso (osimertinib) in combination...
HDFC Bank Ltd leads losers in 'A' group
Business Standard India· 3 days agoAstrazeneca Pharma India Ltd, Orient Cement Ltd, Bajaj Holdings & Investment Ltd and Medplus Health Services Ltd are among the other losers in the BSE's...
EMA fast-tracks review of AstraZeneca’s sipavibart to stop Covid
Pharmaceutical Technology· 6 days agoThe European Medicines Agency (EMA) has accepted AstraZeneca's marketing authorisation application...